Table 1.
Patient demographics, diseases, and medications
| n | 74 |
| Female/Male | 30/44 |
| Age (years) | 69±11 |
| Body weight (Kg) | 87±18 |
| BMI (Kg/m2) | 30.2±5.6 |
| SBP (mmHg) | 133±24 |
| DBP (mmHg) | 73±13 |
| Serum glucose (mg/dL) | 128±49 |
| Underlying disease, n | |
| Coronary artery disease | 54 |
| Peripheral vascular disease | 6 |
| HFrEF (EF=30±8) | 9 |
| HFpEF (EF=58±5) | 6 |
| Prior AMI | 25 |
| Hypertension | 68 |
| Type 1 diabetes | 2 |
| Type 2 diabetes | 25 |
| COPD | 11 |
| Stroke | 9 |
| Hyperlipidemia | 50 |
| Medications, n | |
| Aspirin | 44 |
| Lipid lowering | 49 |
| Insulin | 8 |
| Oral antidiabetic drug | 17 |
| Beta blocker | 44 |
| ACEI/ARB | 40 |
| Diuretic | 33 |
| Anticoagulant | 25 |
| Calcium channel blocker | 24 |
|
| |
| Surgical procedure, % | |
| CABG | 54 |
| Valve Replacement | 21 |
n, number of patients studied; for continues variables mean ± SD are shown.
BMI- body mass index, SBP- systolic blood pressure, DBP- diastolic blood pressure, HFrEF- heart failure with reduced ejection fraction, HFpEF- heart failure with preserved ejection fraction, EF- ejection fraction, AMI- previous acute myocardial infarction, COPD, chronic obstructive pulmonary disease, ACEI/ARB- angiotensin converting enzyme inhibitors/angiotensin receptor blockers, CABG- coronary artery bypass graft.